Identification of novel immune adjuvants and their acting mechanism on dendritic cell function

新型免疫佐剂的鉴定及其对树突状细胞功能的作用机制

基本信息

  • 批准号:
    16590403
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2004
  • 资助国家:
    日本
  • 起止时间:
    2004 至 2005
  • 项目状态:
    已结题

项目摘要

Dendritic cells (DCs) are critically involved in host defense by recognizing a variety of microorganism-derived molecular components, i.e. immune adjuvants, and producing various cytokines. A group of transmembrane proteins, Toll-like receptors (TLRs), are critical for these processes. I have clarified some of these mechanisms by utilizing several gene targeting mice. I have already identified antiviral reagents, imidazoquinoline derivatives, as TLR7 ligands and also revealed that virus-derived single stranded RNAs can also function as TLR7 ligands. TLR3 and TLR4 can recognize double stranded RNAs and lipopolysaccarides (LPS), respectively, and their signaling can induce type I interferons (IFNs). IκB kinase (IKK) family members, IKKε/ι and TBK1, were found to be critical for TLR3/4-induced type I IFN production. These IKKs were also involved in virus-induced type I IFN production. A DC subset, plasmacytoid DC, expresses TLR7 and TLR9 exclusively among TLRs. Because TLR9 is involved in recognizing CpG DNA, it can be assumed that PDC can be regarded as nucleic acid-recognizing DC. Notably, PDC is unique in producing type I IFN, especially IFN-α, in response to TLR7/9 signaling. Another IKK family member, IKKα, was found to be critical for TLR7/9-induced type I IFN production from PDC. Furthermore, by utilizing a variety of DCs, IL-12-inducing activity was detected in helminth extracts. The activity was dependent on a cytoplasmic TLR adapter, MyD88, indicating that the extracts include some TLR ligands. These findings should contribute to the establishment of novel drugs for immune regulation.
树突状细胞(DC)通过识别多种微生物来源的分子成分,即免疫佐剂,并产生各种细胞因子,在宿主防御中发挥重要作用。一组跨膜蛋白,Toll样受体(TLRs),对这些过程至关重要。我已经利用几只基因打靶的小鼠阐明了其中的一些机制。我已经确定了抗病毒试剂,咪唑喹啉衍生物,作为TLR7配体,并揭示了病毒来源的单链RNA也可以作为TLR7配体。TLR3和TLR4分别识别双链RNA和脂多糖,它们的信号转导可以诱导型干扰素(IFN)。IκB激酶(IKK)家族成员IKKε/ι和TbK1在TLR3/4诱导的I型干扰素产生中起关键作用。这些IKK还参与了病毒诱导的I型干扰素的产生。树突状细胞亚群,浆细胞样树突状细胞,在TLRs中唯一表达TLR7和TLR9。由于TLR9参与识别CpG DNA,因此可以认为PDC是一种核酸识别树突状细胞。值得注意的是,pDC在产生I型干扰素,特别是干扰素-α方面是独一无二的,以响应TLR7/9信号。另一个IKK家族成员IKKα在TLR7/9诱导的pDC产生I型干扰素过程中起关键作用。此外,通过利用多种DC,在蠕虫提取物中检测到了IL-12的诱导活性。其活性依赖于细胞质TLR接头MyD88,这表明提取物中含有一些TLR配体。这些发现应该有助于建立新的免疫调节药物。

项目成果

期刊论文数量(46)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
CXCL13 is an arrest chemokine for B cells in high endothelial venules
  • DOI:
    10.1182/blood-2005-01-0133
  • 发表时间:
    2005-10-15
  • 期刊:
  • 影响因子:
    20.3
  • 作者:
    Kanemitsu, N;Ebisuno, Y;Miyasaka, M
  • 通讯作者:
    Miyasaka, M
インターフェロンーα制御剤
干扰素-α调节剂
  • DOI:
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Complement C1q regulates LPS‐induced cytokine production in bone marrow‐derived dendritic cells
  • DOI:
    10.1002/eji.200324026
  • 发表时间:
    2004-01
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Masahide Yamada;K. Oritani;T. Kaisho;J. Ishikawa;H. Yoshida;Isao Takahashi;Shin-ichiro Kawamoto;N. Ishida;H. Ujiie;H. Masaie;M. Botto;Y. Tomiyama;Y. Matsuzawa
  • 通讯作者:
    Masahide Yamada;K. Oritani;T. Kaisho;J. Ishikawa;H. Yoshida;Isao Takahashi;Shin-ichiro Kawamoto;N. Ishida;H. Ujiie;H. Masaie;M. Botto;Y. Tomiyama;Y. Matsuzawa
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
  • DOI:
    10.1126/science.1093616
  • 发表时间:
    2004-03-05
  • 期刊:
  • 影响因子:
    56.9
  • 作者:
    Diebold, SS;Kaisho, T;Sousa, CRE
  • 通讯作者:
    Sousa, CRE
CpG RNA: Identification of Novel Single-Stranded RNA That Stimulates Human CD14+CD11c+ Monocytes
  • DOI:
    10.4049/jimmunol.174.4.2273
  • 发表时间:
    2005-02
  • 期刊:
  • 影响因子:
    0
  • 作者:
    T. Sugiyama;M. Gursel;F. Takeshita;C. Coban;J. Conover;T. Kaisho;S. Akira;D. Klinman;K. Ishii
  • 通讯作者:
    T. Sugiyama;M. Gursel;F. Takeshita;C. Coban;J. Conover;T. Kaisho;S. Akira;D. Klinman;K. Ishii
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAISHO Tsuneyasu其他文献

KAISHO Tsuneyasu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAISHO Tsuneyasu', 18)}}的其他基金

Elucidation of behavior and functions of a dendritic cell subset with high crosspresenting activity
阐明具有高交叉呈递活性的树突状细胞亚群的行为和功能
  • 批准号:
    23659245
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Clarification of molecular mechanisms for regulating dendritic cell subset functions
阐明调节树突状细胞亚群功能的分子机制
  • 批准号:
    23390124
  • 财政年份:
    2011
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Molecular mechanisms for type I interferon production by Toll-like receptor-stimulated dendritic cells
Toll样受体刺激树突状细胞产生I型干扰素的分子机制
  • 批准号:
    20390146
  • 财政年份:
    2008
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Dendritic cell activation mechanisms by nucleic by nucleic acid immune adjuvants.
核酸免疫佐剂通过核酸激活树突状细胞的机制。
  • 批准号:
    18590483
  • 财政年份:
    2006
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dendritic cell activation mechanism by Toll-like receptors
Toll样受体的树突状细胞激活机制
  • 批准号:
    14570280
  • 财政年份:
    2002
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of NK cell dysfunction in C/EBP-γ deficient mice
C/EBP-γ缺陷小鼠NK细胞功能障碍的机制
  • 批准号:
    12670304
  • 财政年份:
    2000
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanism of B cell proliferation and diffentiation in peripheral lymphoid organs
外周淋巴器官B细胞增殖和分化的机制
  • 批准号:
    10670313
  • 财政年份:
    1998
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Exercise as an Immune Adjuvant for Gamma Delta T-cell Therapies in Hematologic Malignancies
运动作为血液恶性肿瘤 Gamma Delta T 细胞疗法的免疫佐剂
  • 批准号:
    10577605
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
The role of unfolded protein responses in cholera toxin-induced immune adjuvant effect
未折叠蛋白反应在霍乱毒素诱导的免疫佐剂作用中的作用
  • 批准号:
    19K07628
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of endogenous immune adjuvant in Japanese cedar pollen
日本柳杉花粉中内源性免疫佐剂的分析
  • 批准号:
    18K06723
  • 财政年份:
    2018
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Novel Innate Immune Adjuvant for Avian Influenza. West Nile Virus, and ZIKA Vaccines
用于禽流感的新型先天免疫佐剂。
  • 批准号:
    9543270
  • 财政年份:
    2017
  • 资助金额:
    $ 2.3万
  • 项目类别:
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, Zika and Japanese Encephalitis Virus vaccines
靶向 IRF 的免疫佐剂增强西尼罗河病毒、登革热病毒、寨卡病毒和日本脑炎病毒疫苗的免疫原性
  • 批准号:
    9492480
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines
靶向 IRF 的免疫佐剂增强西尼罗河病毒、登革热病毒和日本脑炎病毒疫苗的免疫原性
  • 批准号:
    9302594
  • 财政年份:
    2016
  • 资助金额:
    $ 2.3万
  • 项目类别:
The development of non-invasive new immune adjuvant using enzymatically synthesized-lignin polymer
酶法合成木质素聚合物非侵入性新型免疫佐剂的研制
  • 批准号:
    15K18701
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Targeting IRFs for Immune Adjuvant Enhancement of Vaccine Immunogenicity in West Nile Virus, Dengue Virus, and Japanese Encephalitis Virus vaccines
靶向 IRF 的免疫佐剂增强西尼罗河病毒、登革热病毒和日本脑炎病毒疫苗的免疫原性
  • 批准号:
    9113454
  • 财政年份:
    2015
  • 资助金额:
    $ 2.3万
  • 项目类别:
Oxidatively modified DNA as immune adjuvant and autoimmune trigger in the skin (A28*)
氧化修饰 DNA 作为皮肤免疫佐剂和自身免疫触发剂 (A28*)
  • 批准号:
    251379063
  • 财政年份:
    2014
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Collaborative Research Centres
Development of the loco-systemic cancer therapy combining localized radiation and novel immune adjuvant mesoporous silica
局部放射与新型免疫佐剂介孔二氧化硅相结合的局部系统癌症治疗的发展
  • 批准号:
    26670548
  • 财政年份:
    2014
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了